Received Feb 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Arterial clot to left renal artery; This spontaneous case was reported by a consumer and describes the occurrence of RENAL ARTERY THROMBOSIS (Arterial clot to left renal artery) in a 36-year-old male patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. The suspect product included Pre-filled Syringe injection for COVID-19 prophylaxis. No Medical History information was reported. On 26-Sep-2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) .5 milliliter. On an unknown date, the patient started Pre-filled Syringe (unknown route) at an unspecified dose. On 01-Oct-2024, after starting mRNA-1273.712 (SPIKEVAX 2024-2025 PFS), the patient experienced RENAL ARTERY THROMBOSIS (Arterial clot to left renal artery) (seriousness criterion medically significant). At the time of the report, RENAL ARTERY THROMBOSIS (Arterial clot to left renal artery) outcome was unknown. Concomitant medication was not provided. It was unknown if the patient experienced any additional symptoms or events. Treatment medication was not reported.; Reporter's Comments: Company Comment: The benefit-risk relationship of the product is not affected by this report.